Hospitalized patients are being asked to buy medical equipment, including medicines and bandages, as they are out of stock at Mater Dei Hospital, according to relatives. More than 20 people described on social media having had to leave their loved one’s bedside to go to a pharmacy at the request… Continue Reading Mater Dei patients sent to buy their own medicine, relatives say
Pictured: A boy sitting in a wheelchair on a beach/iStock, ChiccoDodiFC The FDA on Thursday approved Santhera Pharmaceuticals’ new corticosteroid vamorolone, now marketed under the brand name Agamree, for the treatment of Duchenne muscular dystrophy. The announcement was made by Florida-based Catalyst Pharmaceuticals, which paid $90 million upfront in June… Continue Reading FDA Approves New Corticosteroid Treatment Option for DMD Patients | BioSpace
Jeffrey M. Sobell, MD Credit: Tufts Medical Center Patients with moderate-to-severe plaque psoriasis receiving deucravacitinib showed improvements in efficacy, including Psoriasis Area and Severity Index (PASI) scores and static Physicians’ Global Assessment (sPGA) response rates, according to data presented at the Fall 2023 Clinical Dermatology Conference.1 These results, observed at… Continue Reading Deucravacitinib improves PASI scores in patients with plaque psoriasis
Yasir Ali is a 35-year-old Pakistani day laborer who earns less than $4 (3.7) per day. His brother suffers from epilepsy and requires daily medication. Speaking to DW, Yasir said the official price of a pack of epilepsy tablets is 300 Pakistani rupees (a little over a dollar), but he… Continue Reading Pakistan: Soaring drug prices leave patients struggling DW 10/24/2023
Nabiximols, the cannabis-based oral spray sold as Sativex, is available for reimbursement as an adjunctive treatment for moderate to severe spasticity in adults with multiple sclerosis (MS) in Ireland who have not responded as expected from other spasticity medications. Marked by muscle stiffness and involuntary spasms or contractions, spasticity is… Continue Reading Sativex reimbursed in Ireland for eligible MS patients with spasticity